Results 91 to 100 of about 4,617,323 (138)

Role of a Tissue Factor Pathway Inhibitor, the Plasma Proteinase ADAMTS-13 and its Inhibitor in the Pathogenesis of Acute Respiratory Distress Syndrome in A/H1N1 Influenza

Общая реаниматология, 2011
Objective: to study the role of a tissue factor pathway inhibitor (TFPI), the metalloproteinase ADAMTS-13, and its inhibitor in the pathogenesis of acute respiratory distress syndrome (ARDS) in A/H1N1 influenza. Subjects and methods.
E. V. Prutkina, A. V Malyarchikov, N. N. Tsybikov, K. G. Shapovalov, N. V. Isakova   +4 more
doaj   +1 more source

The relationship between coronary collateral circulation and ADAMTS-1 and ADAMTS-13 levels in ischemic heart patients [PDF]

, 2019
Tıp Fakültesi, Tıbbi Biyokimya Ana Bilim Dalı, Tıbbi Biyoloji Bilim DalıGiriş ve Amaç: Koroner kollateral dolaşım, koroner arter hastalığının seyrinde ve prognozunda rol alan çok önemli bir klinik antitedir.
Gül, Abdülhakim Hasan
core   +1 more source

Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease

Clinics, 2013
OBJECTIVE: To analyze the preoperative plasma antigenic concentration and activity of von Willebrand factor and its main cleaving protease ADAMTS-13 in pediatric patients with cyanotic congenital heart disease undergoing surgical treatment and ...
Rosangela P.S. Soares, Sérgio P. Bydlowski, Marcelo B. Jatene, Janete Ferreira Hironaka, Antonio Augusto Lopes   +4 more
doaj  

Investigation of ADAMTS-13 levels in patients with COVID-19 infection

Journal of Infection in Developing Countries
Introduction: Coronavirus disease 2019 (COVID-19) patients are predisposed to thrombotic events. COVID-19 coagulopathy can be associated with ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type I repeats 13) levels. ADAMTS-13, the
Hüseyin H Kutlu, Arzu Sahin, Soycan Mizrak, Abdurrahman Yilmaz, Songul Doganay, Serdar Gungor, Sema Yilmaz   +6 more
doaj   +1 more source

Comparison of assays to evaluate ADAMTS13 activity in patients’ plasma

, 2008
BACKGROUND : several assays for measurement of ADAMTS-13 activity have been developed. Although the performance characteristics of these methods were recently evaluated (Tripodi A, et al.
C. Valsecchi, P.M. Mannucci, R. Palla, L. Beretta, M. Spreafico, F. Peyvandi   +5 more
core   +2 more sources

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up

Research and Practice in Thrombosis and Haemostasis
Background: Management of patients with refractory or frequently relapsing (r/r) immune thrombotic thrombocytopenic purpura (iTTP) remains challenging, with no established consensus on optimal therapeutic strategies.
Roman Schimmer, Jana van den Berg, Marissa Schraner, Alice Trinchero, Andreas Holbro, Johanna A. Kremer Hovinga, Jan-Dirk Studt   +6 more
doaj   +1 more source

Reduced ADAMTS-13 level negatively correlates with inflammation factors in plasma of acute myeloid leukemia patients

, 2017
ADAMTS-13 is crucial for maintaining the normal size of vWF. Besides thrombotic thrombocytopenic purpura (TTP), decreased ADAMTS-13 had also been reported in patients with malignancy.
Zhao, Jingzhong, Song, Ying, Wang, Hui, Xu, Qinzhu, Liu, Chen, Zhao, Lei   +5 more
core   +1 more source

A Global Assessment of Coagulation Profile and a Novel Insight into Adamts-13 Implication in Neonatal Sepsis. [PDF]

Biology (Basel), 2023
Papadogeorgou P, Boutsikou T, Boutsikou M, Pergantou E, Mantzou A, Papassotiriou I, Iliodromiti Z, Sokou R, Bouza E, Politou M, Iacovidou N, Valsami S.   +11 more
europepmc   +1 more source

Targeting the von Willebrand Factor-ADAMTS-13 axis in sickle cell disease. [PDF]

J Thromb Haemost, 2023
Ellsworth P, Sparkenbaugh EM.
europepmc   +1 more source

A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA RELATED TO MALIGNITY AND CHEMOTHERAPY

Hematology, Transfusion and Cell Therapy
Objective: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening multisystem disease. TTP progresses with Microangiopathic hemolytic anemia (MAHA), fever, thrombocytopenia, neurological symptoms, and renal failure.
Ebru Kavak Yavuz, Songül Beskisiz Dönen, Etem Özkaya, Esra Pirinççi, Abdullah Karakuş, Orhan Ayyıldız   +5 more
doaj   +1 more source